👌🏻 SGLT2 🥰
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
SGLT2 inhibitors may offer benefit beyond diabetes | Nature Reviews Nephrology https://t.co/wyhUP93JRk
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
Must read review @FJDNefrologia
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibitors beyond T2DM https://t.co/2P2TIJ3OoU https://t.co/p8QEY8m9SC
SGLT2 inhibitors may offer benefit beyond diabetes https://t.co/Q0FrdARNtD
RT @jardine_meg: The latest meta-analysis in a rapidly evolving field from @AmyKang23 shows yet again how profoundly effective SGLT2is are.…
RT @TrialsCentre: 2020 has been an impressive year for #SGLT2 inhibitors! We now know SGLT2 inhibitors improve #kidney and #heart failure o…
RT @jardine_meg: The latest meta-analysis in a rapidly evolving field from @AmyKang23 shows yet again how profoundly effective SGLT2is are.…
RT @TrialsCentre: 2020 has been an impressive year for #SGLT2 inhibitors! We now know SGLT2 inhibitors improve #kidney and #heart failure o…
RT @jardine_meg: The latest meta-analysis in a rapidly evolving field from @AmyKang23 shows yet again how profoundly effective SGLT2is are.…
The latest meta-analysis in a rapidly evolving field from @AmyKang23 shows yet again how profoundly effective SGLT2is are. Very consistent improvements for kidney disease & heart failure - regardless of diabetes status. Results of EMPA-Kidney eagerly a
2020 has been an impressive year for #SGLT2 inhibitors! We now know SGLT2 inhibitors improve #kidney and #heart failure outcomes in people without diabetes. Check out our Year in Review by @amykang23 @jardine_meg in @natrevneph. Full text in https://t.co/z